GSK ONE LIMITED

Company Registration Number:
09280983 (England and Wales)

Unaudited abridged accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

GSK ONE LIMITED

Contents of the Financial Statements

for the Period Ended 31 October 2024

Balance sheet
Notes

GSK ONE LIMITED

Balance sheet

As at 31 October 2024


Notes
2024
2023


£
£
Fixed assets
Tangible assets: 3 28,311 15,411
Total fixed assets: 28,311 15,411
Current assets
Debtors:   32,404 61,060
Cash at bank and in hand: 52,489 50,006
Total current assets: 84,893 111,066
Creditors: amounts falling due within one year:   (39,533) (42,838)
Net current assets (liabilities): 45,360 68,228
Total assets less current liabilities: 73,671 83,639
Creditors: amounts falling due after more than one year:   (5,327) (15,667)
Provision for liabilities:   (1,380)
Total net assets (liabilities): 68,344 66,592
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 68,342 66,590
Shareholders funds: 68,344 66,592

The notes form part of these financial statements

GSK ONE LIMITED

Balance sheet statements

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 29 October 2025
and signed on behalf of the board by:

Name: K Haswell
Status: Director

The notes form part of these financial statements

GSK ONE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

GSK ONE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

2. Employees

2024 2023
Average number of employees during the period 26 26

GSK ONE LIMITED

Notes to the Financial Statements

for the Period Ended 31 October 2024

3. Tangible Assets

Total
Cost £
At 01 November 2023 34,071
Additions 12,900
At 31 October 2024 46,971
Depreciation
At 01 November 2023 18,660
At 31 October 2024 18,660
Net book value
At 31 October 2024 28,311
At 31 October 2023 15,411